feed,title,long_url,short_url
SeekingAlpha,Syndax: SNDX-6352's Pivotal Trial Initiation In 2021 And $176M In Cash,https://seekingalpha.com/article/4394900,
SeekingAlpha,FactSet Research Systems: An Updated Full-Cycle Analysis,https://seekingalpha.com/article/4394911,
SeekingAlpha,Regeneron: AbbVie's Dupixent Scare Could Subside,https://seekingalpha.com/article/4394910,
